HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ALVAC vaccine

a plaque cloned isolated from attenuated canarypox strain; used as a vaccine for canaries

Networked: 5 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Viral Vaccines: 462
      - ALVAC vaccine: 5

Experts

1.	Fan, Xiuzhen: 1 article (11/2017)
2.	Hou, Wei: 1 article (11/2017)
3.	Hu, Haitao: 1 article (11/2017)
4.	Kanneganti, Thirumala-Devi: 1 article (11/2017)
5.	Kim, Jerome H: 1 article (11/2017)
6.	Liu, Connie: 1 article (11/2017)
7.	Liu, Fengliang: 1 article (11/2017)
8.	Michael, Nelson L: 1 article (11/2017)
9.	Niu, Qingli: 1 article (11/2017)
10.	Robb, Merlin L: 1 article (11/2017)

Related Diseases

1.	Colorectal Neoplasms (Colorectal Cancer) 05/01/2002 - "A Phase I/II dose-escalation study was performed that evaluated the effect of a recombinant canarypoxvirus (ALVAC) vaccine encoding wild-type human p53 in 15 patients with advanced colorectal cancer. "
2.	Bites and Stings (Sting) 11/01/2017 - "Therefore, our study identifies the AIM2 inflammasome and cGAS/IFI16-STING-type I IFN pathway as a novel mechanism for host innate immunity to the ALVAC vaccine vector."
3.	Acquired Immunodeficiency Syndrome (AIDS) 12/15/2005 - "Pediatric AIDS Clinical Trials Group protocol 326 is a study of 2 formulations of recombinant canarypox ALVAC vaccine (vCP205) against human immunodeficiency virus type 1 (HIV-1). "
4.	Infections 07/16/2009 - "We describe the development and preliminary characterization of a recombinant canarypox virus vectored (ALVAC) vaccine for protective immunization of equids against African horse sickness virus (AHSV) infection. " 07/01/2000 - "The model was used to determine if parenteral or mucosal immunization of infant ferrets at 3 and 6 weeks of age with attenuated vaccinia virus (NYVAC) or canarypox virus (ALVAC) vaccine strains expressing the CDV hemagglutinin (H) and fusion (F) protein genes (NYVAC-HF and ALVAC-HF) would induce serum neutralizing antibody and protect against challenge infection at 12 weeks of age. "

Related Drugs and Biologics

1.	Inflammasomes
2.	Neutralizing Antibodies
3.	Proteins (Proteins, Gene)
4.	Hemagglutinins (Hemagglutinin)